CARBOMIMETICS

Carbomimetics est dédiée à la découverte et au développement précoce de médicaments à base de sucre contre le cancer

Start-up entrée en incubation en 2012

A breakthrough approach for sugar drug discovery and optimization
Discovery & early development of original medicines from innovative glycochemistry.
CarboMimetics scientific foundations are built around its innovative platform – GlycoSMART® – devoted to Rationale & Smart De Novo Design, Synthesis and Optimization of Sugar based Drugs. Having already 2 very promising programs under development in oncology, CarboMimetics vision is to become the worldwide leader in Glycochemistry Drug Discovery.

Suivez nous sur Twitter

pour plus de

proximité

précision contacts

passion